Compare Evotaz vs. Triumeq

Evotaz (atazanavir/cobicistat) and Triumeq (abacavir/dolutegravir/lamivudine) are both medications used to treat HIV, but they have some key differences. Evotaz is a combination of two drugs: atazanavir, a protease inhibitor, and cobicistat, a booster that helps maintain higher levels of atazanavir in your blood. It must be taken with other HIV medications and always with food. On the other hand, Triumeq is a single-tablet regimen that combines three drugs: abacavir and lamivudine, both nucleoside reverse transcriptase inhibitors (NRTIs), and dolutegravir, an integrase inhibitor. Triumeq can be taken with or without food and is a complete treatment on its own. Before starting Triumeq, you need a genetic test to check for a specific trait that could cause a severe allergic reaction, which is not required for Evotaz. Additionally, Triumeq is available in a dissolvable tablet form for children, while Evotaz is only available as a standard tablet. Both medications have their own sets of side effects and interactions, so it's important to discuss with your healthcare provider which option is best for you.